OPtimal Type 2 dIabetes Management Including Benchmarking and Standard Treatment in CEEMEA

Clinical trial NCT01694758 · COMPLETED

Trial details

NCT number: NCT01694758
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Diabetes Mellitus, Non-Insulin-Dependent

Start date: 2012-11-01
Primary completion: 2014-03-01
Enrollment: 733

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.